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Background: Growing evidence suggests that exposure to environmental chemicals, such as pesticides, impacts
renal function and chronic kidney disease (CKD). However, it is not clear if pesticides may affect CKD progression
and no studies exist in children.
Objectives: The objective of this study was to examine associations between serially measured urinary OP
pesticide metabolites and clinical and laboratory measures of kidney function over time among children with
CKD.
Methods: This study used data on 618 participants enrolled in the CKD in Children study (CKiD), a cohort study of
pediatric CKD patients from the US and Canada. Children were followed over an average of 3.0 years (standard
deviation (SD) = 1.6) between 2005 and 2015. In serially collected urine samples over time, six nonspecific
dialkyl phosphate (DAP) metabolites of OP pesticides were measured. Biomarkers of tubular injury (kidney
injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL)) and oxidant stress (8-hydroxy2′ -deoxyguanosine (8-OHdG) and F2-isoprostane) were determined in the same specimens. Estimated glomerular
filtration rate (eGFR), proteinuria, and blood pressure were assessed annually.
Results: DAPs were associated with increased KIM-1 and 8-OHdG throughout follow-up. A standard deviation
∑
increase in diethyl metabolites was associated with increases of 11.9% (95% Confidence Interval (CI): 4.8%,
19.4%) and 13.2% (95% CI: 9.3%, 17.2%) in KIM-1 and 8-OHdG over time, respectively. DAPs were associated
with lower eGFR at baseline and higher eGFR over subsequent years.
Conclusions: These findings provide preliminary evidence suggesting that urinary DAP metabolites are associated
with subclinical kidney injury among children with CKD, which may signal the potential for clinical events to
manifest in the future. The results from this study are significant from both a clinical and public health
perspective, given that OP pesticide exposure is a modifiable risk factor.
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biomarkers of tubular injury (kidney injury molecule-1 (KIM-1) and
neutrophil gelatinase-associated lipocalin (NGAL)) over time in a wellcharacterized cohort of children and adolescents with CKD; and (2) to
determine a potential mechanism of action by evaluating longitudinally
assessed oxidative stress biomarkers (i.e., 8-hydroxy-2′ -deoxyguanosine
(8-OHdG) and F2-isoprostane.

1. Introduction
Chronic kidney disease (CKD) is a serious condition associated with
significant comorbidities, mortality, and healthcare costs. Due to med
ical and technological advances, survival has improved, leading to
greater prevalence, which is approximately 55–60 per million children
in western nations (Becherucci et al., 2016) Although still relatively
uncommon in children, CKD is associated with substantial morbidity,
long-term health consequences, and healthcare costs, especially as it
progresses to end stage kidney disease (ESKD) (US Renal Data System
2018 Annual Data Report, 2019a, b, c, d). More research is needed on
the determinants of CKD progression to ESKD and prevention strategies.
Identification of potentially modifiable risk factors is a key goal.
Progression of CKD to ESKD occurs over time and factors such as
blood pressure, hyperuricemia, and anemia have been shown to accel
erate the rate of kidney function decline in children (Rodenbach et al.,
2015; Staples et al., 2010; US Renal Data System 2018 Annual Data
Report, 2019a; Warady et al., 2015; Wong et al., 2012). Notably, few
potentially modifiable risk factors have been identified in relation to
CKD progression. However, there is growing evidence suggesting that
non-traditional factors including exposure to environmental chemicals,
such as pesticides, may affect renal function (Sullivan and Krieger,
2001), which motivates the hypothesis that they could play a role in
CKD progression as well.
Organophosphate (OP) and organochlorine pesticides have emerged
as potential contributors to CKD of unknown etiology (CKDu), which is
defined as unexplained CKD that occurs in the absence of typical risk
factors or presentation such as diabetes and glomerular nephritis (Pearce
and Caplin, 2019). Reports of farmworkers with occupational histories
of pesticide application in Central America, India, and Sri Lanka moti
vated this hypothesis (Herrera et al., 2014; Jayatilake et al., 2013;
Valcke et al., 2017), but substantive evidence is still lacking (Pearce and
Caplin, 2019). Epidemiologic studies conducted among farmworkers
and their wives have also documented links between self-reported
pesticide application and ESKD (Lebov et al., 2016; Lebov et al.,
2015). Several studies have identified associations between serum bio
markers of pesticide exposure and CKDu and correlates of reduced
kidney function in clinical populations in India (Ghosh et al., 2017;
Siddarth et al., 2014; Siddharth et al., 2012). Results from toxicological
studies have been consistent and indicate that this may occur through
increased oxidant stress (Poovala et al., 1999; Poovala et al., 1998; Shah
and Iqbal, 2010). For example, one OP, diazinon, enhances renal lipid
peroxidation and diminishes antioxidant capacity (Shah and Iqbal,
2010). However, meta-analyses and reports from working groups have
concluded that there is insufficient evidence to support a contributing
role of pesticides in CKDu, citing the need for more high-quality studies
using biomonitoring for exposure assessment (Crowe et al., 2019;
González-Quiroz et al., 2018; Valcke et al., 2017; Wesseling et al., 2020).
The general (i.e., non-occupational) population is exposed to OP
pesticide residues primarily through diet (Cequier et al., 2017; Lu et al.,
2008; Quirós-Alcalá et al., 2012; Trasande, 2017). Exposure is prevalent,
with at least 74% of children in the US having detectable levels of at
least one dialkyl phosphate (DAP) metabolite, and children having
significantly higher levels than adults (Barr Dana et al., 2004; Jain,
2016). However, no studies have examined OP pesticide exposure in
relation to renal function among children with CKD. Unlike other
established risk factors for CKD progression, exposure to OP pesticides is
potentially modifiable, given that studies have shown that exposure
levels can be reduced by consuming organic foods (Bradman et al., 2015;
Lu et al., 2008; Lu et al., 2006).
Therefore, we conducted this study with the following objectives: (1)
to examine the associations between serially measured urinary OP
pesticide metabolites and clinical measures of kidney function (i.e.,
eGFR, proteinuria, systolic blood pressure (SBP), diastolic blood pres
sure (DBP), and time to ESKD or renal replacement therapy (RRT)) and
laboratory measures of subclinical kidney damage (i.e., urinary

2. Material and methods
2.1. Study population
The CKD in Children (CKiD) study is a multi-centered prospective
cohort study of children aged 6 months to 16 years with mild-tomoderate CKD with the overall goal of identifying predictors and
sequelae of CKD progression (Furth et al., 2006). The CKiD study pro
cedures and protocol have been previously described (Furth et al.,
2006). Briefly, pediatric patients with prevalent CKD were recruited at a
network of sites in the US and Canada. Children were enrolled, assessed
3–6 months after study entry (i.e., baseline), and annually thereafter.
These annual assessments included a physical examination, biospecimen
collection (e.g., urine, serum, etc.), and questionnaire administration
and were conducted until the initiation of RRT for treatment of ESKD.
Biospecimens were stored in a central biorepository for future use in
ancillary studies. The New York University (NYU) School of Medicine
Institutional Review Board deemed this project exempt from review due
to data collection being complete and the dataset de-identified.
2.2. Exposure measures
Urine samples serially collected at annual visits were used for
exposure assessment. Six DAP metabolites of OP pesticides, dimethyl
phosphate (DMP), diethylphosphate (DEP), dimethylthiophosphate
(DMTP), diethylthiophosphate (DETP), dimethylphosphorodithidate
(DMDTP), and diethyldithiophosphate (DEDTP), and creatinine were
analyzed at the Wadsworth Center, New York State Department of
Health, Albany, NY. The target DAP metabolites were analyzed by solid
phase extraction. Briefly, 0.5 mL of urine was transferred into a 15-mL
polypropylene tube, and 2.5 ng each of isotope-labeled internal stan
dard (IS) mixture (six ISs for each of the six target analytes) was added.
The urine samples were mixed with 1.5 mL of 2% formic acid (v/v). The
samples were then passed through Oasis WAX cartridges (50 mg/3 mL)
that were conditioned with methanol (3 mL) and HPLC-grade water (3
mL). After loading samples, cartridges were washed with HPLC-grade
water (3 mL) and acetonitrile/HPLC-grade water (3 mL; 50:50, v/v).
Analytes were recovered by elution with 3 mL of 5% ammonia in
methanol. The extracts were evaporated to near-dryness under nitrogen
(Organomation Associates Inc., West Berlin, MA), fortified in 250 µL of
acetonitrile/20 mM ammonium acetate (90:10, v/v), and filtered
through a 0.22 µm nylon filter (Spin-X, Costar, Corning, NY) prior to
instrumental analysis.
Chromatographic separation of the analytes was achieved with a
Waters ACQUITY Class I HPLC system (Waters, Milford, MA) fitted with
a Luna HILIC column (3 µm, 100 × 3 mm, Phenomenex). Injection
volume was 1.5 µL, and mobile phase flow was 400 µL/min. The mobile
phase consisted of acetonitrile (A) and 20 mM ammonium acetate in
acetonitrile at pH 8.5 (B). The gradient started with 99% B and held for
6 min, linearly decreased to 50% within 0.1 min and held for 1.4 min,
and reverted to initial condition within 0.1 min and held for 2.4 min.
The total run time was 10 min. Mass spectrometric analysis was per
formed on an Applied Biosystems API 5500 electrospray triple quadru
pole mass spectrometer (ESI-MS/MS; Applied Biosystems, Foster City,
CA, USA). The turbo ion spray source setting in the negative ionization
mode were: curtain gas (CUR) 30 psi; collision gas (CAD) 10 psi; source
temperature 550 ◦ C; ion source gas 1 70 psi; ion source gas 2 70 psi; and
ion spray voltage –3500 V. Nitrogen was used as CUR and CAD.
For all exposures, measures below the limit of detection (LOD) were
2
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substituted by the LOD/√2 (Hornung and Reed, 1990). DAP metabolites
∑
were analyzed singularly and as molar sums: dimethyl (DM) metab
∑
olites (DMP, DMTP, and DMDTP), diethyl (DE) metabolites (DEP and
∑
DETP), and DAP (DMP, DMTP, DMDTP, DEP, and DETP). All calcu
lations excluded DEDTP because it was detected in < 10% of samples.

in order to approximate normal distributions.
To estimate longitudinal associations between repeated measures of
DAPs and renal function measures and oxidative stress biomarkers,
linear mixed effects models (LMMs) were fit with random intercepts and
a first-order autoregressive correlation structure to account for both the
intra-individual correlation of measures over time and inter-individual
variation (formula shown in Supplemental Material). Separate models
were fit for each exposure-outcome combination. Models were run for
∑
each individual DAP metabolite as well as each molar sum (i.e., DM,
∑
∑
DE, and DAP) and all outcomes of interest (i.e., eGFR, UPCR, SBP,
DBP, KIM-1, NGAL, 8-OHdG, and F2-isoprostane). Models were fit with
DAP metabolites expressed on the volume basis (ng/ml or nmol/L) and
urinary creatinine was controlled for as a covariate (Barr et al., 2004).
All models additionally adjusted for continuous time since the baseline
visit, a quadratic term for time, and baseline covariates hypothesized to
act as confounders and/or key predictors of the outcome(s) based on
previous literature: sex, race/ethnicity, age, glomerular versus nonglomerular or CAKUT categorization, birthweight, premature birth,
angiotensin converting enzyme inhibitor (ACEI) use, angiotensin re
ceptor blocker (ARB) use, BMI z-score, and SBP z-score (in models for all
outcomes except blood pressure) (Supplemental Figure) (Furth et al.,
2006; Kataria et al., 2017; Kataria et al., 2015; Malits et al., 2018). In
addition, to examine whether associations varied over time as CKD
progressed, we fit all models with cross-product interaction terms be
tween all DAP metabolites and follow-up time. If the interaction with
time was significant (p < 0.05), we reported time-specific associations.
Lastly, in all models, the log-transformed exposure variables were
standardized so that the estimates represented the average change in the
outcome in response to a 1-standard deviation (SD) change in the logtransformed exposure, which facilitates the interpretation of associa
tions across exposures. In the presentation of results in the text for
outcomes that were natural log-transformed (i.e., UPCR, KIM-1, NGAL,
8-OHdG and F2-isoprostane), the β-coefficients were exponentiated so
that they could be interpreted as the percent change in the outcome
response to a 1-SD increase in the log-transformed exposure.
We also fit extended Cox proportional hazards models, which
accommodate time-varying exposures, to estimate associations between
longitudinal DAP metabolites and time to RRT (Kleinbaum and Klein,
2011). Time at risk started at the baseline visit and continued until the
initiation of RRT or censorship at the end of follow-up. Follow-up time
for this analysis was available outside of the clinical study period due to
linkages with medical records, with a median of 5.7 years (IQR: 3.4,
8.0). The proportional hazards assumption was checked for all cova
riates using visual inspection of log–log survival curves and testing of
Schoenfeld residuals and covariate-by-time interaction terms.
Finally, we conducted several sensitivity analyses. First, we consid
ered several parameterizations of exposure including cumulative aver
ages, peak concentrations, and quartiles. We also examined the potential
for non-linear relationships by using generalized additive mixed-effect
models (GAMMs). Second, we evaluated associations between DAP
metabolites and rates of change in renal outcomes using a two-step
approach: (1) estimating the individual slope over time using the indi
vidual repeated outcome measures and (2) using this slope as the
outcome in a model with urinary DAPs. Third, we examined whether the
associations between DAP metabolites and the outcomes of interest
varied by kidney function level by stratifying by eGFR categories at
baseline. Separate models were run among those with eGFR levels ≥ 45
mL/min/1.73 m2 (eGFR category G3a and higher) and < 45 mL/min/
1.73 m2 (eGFR category G3b and lower) (KDIGO, 2013 clinical practice
guideline for the evaluation and management of chronic kidney disease
2013). Third, residential zip code was available on 80% of children. We
examined the impact of controlling for zip-code level poverty measures
(i.e., percent below the poverty line) using American Community Survey
data in our analyses. Fourth, we examined the impact of using an
alternate method for accounting for variation in urinary creatinine
excretion: the covariate-adjusted standardization plus covariate

2.3. Outcomes
2.3.1. Clinical renal function measures
Clinical measures of renal function included eGFR, urinary proteinto-creatinine ratio (UPCR), SBP, and DBP, all measured at each annual
visit. EGFR was calculated using the modified Schwartz (i.e., bedside)
equation (Schwartz et al., 2009). Methods for determining UPCR, SBP,
and DBP have been described previously (Fuhrman et al., 2017; Wong
et al., 2009). Laboratory analysis of total urinary protein was deter
mined using an immunoturbidimetric assay at the central CKiD labo
ratory (University of Rochester). UPCR was then calculated as the ratio
of the total urinary protein concentration to urinary creatinine con
centration. SBP and DBP were measured in the right arm by auscultation
using an aneroid sphygmomanometer three times at 30-second intervals
(Flynn et al., 2008). The mean BP was computed and standardized to zscores according to the National High Blood Pressure Education Pro
gram Fourth Report (National High Blood Pressure Education Program
Working Group on High Blood Pressure in Children and Adolescents,
2004).
Time to ESKD/RRT was determined by the start date of dialysis or
transplantation (Warady et al., 2015).
2.3.2. Laboratory measures of renal damage
Laboratory measures of subclinical renal damage included urinary
tubular injury biomarkers: kidney injury molecule-1 (KIM-1), repre
senting damage to the proximal tubule and neutrophil gelatinaseassociated lipocalin (NGAL), representing damage to the distal tubule.
KIM-1 and NGAL were assayed in stored urine samples at the NYU High
Throughput Biology Laboratory. They were quantified by solid phase
sandwich ELISAs using the Quantikine Human KIM-1 Immunoassay and
Quantikine Human Lipocalin-2 Immunoassay, respectively (R&D Sys
tems, Minneapolis, MN), according to manufacturer instructions. All
analyses were conducted in duplicate. Intra-assay coefficients of varia
tion (CV) ranged from 3.6% to 3.7% for KIM-1 and 2.3%-3.9% for NGAL.
Inter-assay CVs ranged from 0.7% to 4.3% for KIM-1 and 0.6%-4.8% for
NGAL.
2.3.3. Oxidant stress biomarkers
8-OHdG and F2-isoprostane were measured in urine samples with
sufficient volume at the NYU High Throughput Biology Laboratory (N =
2465 samples; N = 618 individuals and N = 1287 samples; N = 522
individuals, respectively) using previously described methods (Jacobson
et al., 2020). Briefly, 8-OHdG was quantified by competitive ELISA using
the OxiSelect™ Oxidative DNA Damage ELISA (Cell Biolabs, Inc., San
Diego, CA) and F2-isoprostane by a competitive enzyme-linked immu
noassay, the OxiSelect™ 8-iso-Prostaglandin F2α ELISA kit.
2.4. Statistical analysis
Distributions of DAP metabolites were examined by calculating
percent detection, geometric means, and selected percentiles. For com
parison, we examined urinary levels of DAP metabolites among National
Health and Nutrition Examination Survey (NHANES) samples from 2011
to 2012 for individuals aged 6–19 years (Centers for Disease Control and
Prevention, 2012).
In preparation for modeling, urinary concentrations of DAP metab
olites were natural log-transformed due to their right skewed distribu
tions to reduce the influence of measures at the upper tail. Outcomes of
interest that were right skewed: UPCR, KIM-1, NGAL, 8-OHdG and F2isoprostane, were natural-log transformed before multivariable analysis
3
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adjustment method (O’Brien et al., 2015). Lastly, because dietary re
strictions may be warranted for certain CKD patients according to dis
ease type (glomerular vs. non-glomerular) which could theoretically
affect OP exposure, we stratified our analysis by disease type.
Analyses were performed using complete case analysis. All analyses
were conducted in R version 3.5.0 for Windows (Team, 2013), using the
package ‘nlme’ (Pinheiro et al., 2018) version 3.1–137 for LMM models.

concentrations were highest among those aged ≤ 8 years and decreased
with age. Overall, urinary concentrations of DAP metabolites among
CKiD participants were lower than those of contemporaneous NHANES
samples (Table 2).
Associations between DAP metabolites and eGFR varied over time
(Fig. 1). At baseline, DAPs were associated with reductions in eGFR (for
a SD increase in ΣDAP, β = − 1.01 mL/min/1.73 m2, 95% Confidence
Interval (CI): − 1.66, − 0.36) (Table 4). Estimates for DE metabolites (DE
and DETP) showed the strongest associations that extended out to 1 year
after baseline. However, at years 2 through 4 after baseline, DAP me
tabolites were associated with increases in eGFR (Supplemental
Table 2). For example, for a SD increase in ΣDAP, eGFR increased by
0.54 mL/min/1.73 m2 (95% CI: 0.02, 1.06) at year 2, 0.89 mL/min/
1.73 m2 (95% CI: 0.32, 1.47) at year 3, and 0.69 mL/min/1.73 m2 (95%
CI: 0.09, 1.29) at year 4. All DAP metabolites exhibited this same trend.
Overall, DAP metabolites were not associated with UPCR, SBP, or DBP
(Table 4 and Supplemental Tables 3 and 4). In addition, DAP metabolites
were not associated with time to RRT (Table 5).
DEP and ΣDE metabolites were associated with increased concen
trations of KIM-1 that persisted over time (Table 6). For an SD increase
in ΣDE, there was an expected increase in KIM-1 of 11.9% (95% CI:
4.8%, 19.4%) (computed from Table 6). DM metabolites also had posi
tive point estimates in association with KIM-1 but were smaller in
magnitude and not statistically significant. DAP metabolites were not
associated with NGAL concentrations.
DAP metabolites were consistently associated with increases in uri
nary 8-OHdG excretion (Table 7). DE metabolites showed the strongest
associations with 8-OHdG. For example, a SD increase in DEP was
associated with a 12.2% increase (95% CI: 8.3%, 16.2%) in 8-OHdG
(computed from Table 7). For DETP, associations were apparent
within the first 2 years after baseline and tended to attenuate over time
(Supplemental Table 5). DAP metabolites were not statistically signifi
cantly associated with increased F2-isoprostane, although some metab
olites, such as DMTP and DMDTP, had positive point estimates.
In sensitivity analyses, modeling the association between DAP me
tabolites and renal outcomes with different parameterizations of expo
sures (i.e., cumulative averages, peak exposure, quartiles, and allowing
for non-linear relationships using GAMMs) yielded results consistent
with the primary analysis (data not shown). When we used a two-step
approach to examine rates of change over time, results were null for
eGFR and biomarkers for tubular injury. However, we observed an in
verse association between urinary DAPs and rate of UPCR change over
time, suggesting that those with higher urinary DAP concentrations had
decreased rates of UPCR over time compared with those with lower
concentrations (Supplemental Table 6). When stratified by baseline
eGFR levels, associations between exposure biomarkers and eGFR, KIM1, and 8-OHdG did not materially change (Supplemental Tables 7–9),
although associations tended to be stronger in magnitude among those
with eGFR ≥ 45. Results were consistent when analyses were repeated
controlling for zip-code level poverty measures () and when we imple
mented the covariate-adjusted standardization plus covariate adjust
ment method for accounting for variation in creatinine excretion
(Supplemental Tables 12–13). Finally, results were consistent in direc
tion when the population was stratified by CKD disease type (i.e.,
glomerular vs. non-glomerular), although estimates were imprecise
among those with glomerular disease because this comprised only 11%
of the cohort (n = 67) (Supplemental Tables 14–16).

3. Results
Between 2005 and 2015, 618 CKiD participants were included in this
study. There were no markedly different demographic or clinical char
acteristics between the subgroup included in this study (59% of the total
enrollment) and the complete CKiD cohort (data not shown) (Atkinson
et al., 2020;). They were followed for an average of 3.0 years (SD = 1.6),
constituting 2469 total visits (mean number of visits ± SD: 4.0 ± 1.6).
Most children were male (63.8%), white (58.3%), and had nonglomerular disease (89.2%) (Table 1). Median age at baseline was
11.0 (interquartile range (IQR): 7.6, 14.6). CKD severity at baseline was
moderate, with an average eGFR = 51.9 mL/min/1.73 m2 (SD = 19.8)
and 39.1% with stage 3B or more advanced disease (eGFR ≤ 44). Median
urinary protein: creatinine ratio was 0.30 at baseline (IQR: 0.1, 0.8), and
SBP and DBP were slightly above average (mean z-scores = 0.32 ± 1.1
and 0.52 ± 1.0, respectively).
At least one DAP metabolite was detected in 100% of samples. DMTP
was the most prevalent metabolite detected (99.9%) and had the
greatest concentrations compared with the other five DAPs, whereas
DEDTP was rarely detected (9.9%) (Table 2). DM and DE metabolites
were moderately correlated (Spearman rho = 0.52, p < 0.0001). All DAP
metabolites exhibited substantial within-person variation over time,
with intraclass correlation coefficients ranging from 0.18 to 0.28. ΣDAP
concentrations tended to decrease over the course of follow-up
(Table 3). Although total urinary DAP concentrations did not vary
across most demographic strata, in bivariate analyses, levels tended to
be greater among Black and Hispanic participants compared with White
and those of other race (Supplemental Table 1). In addition, DAP
Table 1
Characteristics of study population, Chronic Kidney Disease in Children Study
(CKiD), 2005–2015.
Total (N = 618)
Sex, n (%)
Female
Male
Race/Ethnicity, n (%)
White
Black
Hispanic
Multiracial/Other
Age (years) at visit 1, median (IQR)
BMI z-score at visit 1, mean (SD)
Type of kidney disease, n (%)
Non-Glomerular
Glomerular
ARB use, n (%)
ACEI use, n (%)
Birthweight, kg, mean (SD)
Premature, n (%)
eGFR (ml/min/1.73 m2) at visit 1, mean (SD)
UPCR at visit 1, median (IQR)
SBP Z-score at visit 1, mean (SD)
DBP Z-score at visit 1, mean (SD)

224 (36.3)
394 (63.8)
360 (58.3)
102 (16.5)
85 (13.8)
71 (11.5)
11.0 (7.6, 14.6)
0.41 (1.2)
551 (89.2)
67 (10.8)
47 (8.7)
241 (44.8)
3.1 (0.8)
62 (11.5)
51.9 (19.8)
0.30 (0.1, 0.8)
0.32 (1.1)
0.52 (1.0)

4. Discussion

Abbreviations: SD: standard deviation; ACEI: angiotensin converting enzyme
inhibitor; ARB: angiotensin receptor blocker; BMI: body mass index; eGFR:
estimated glomerular filtration rate; UPCR: urinary protein to creatinine ratio;
IQR: interquartile range; SBP: systolic blood pressure; DBP: diastolic blood
pressure.
Percent missing for covariates: age, sex, race/ethnicity, glomerular disease type,
ARB/ACEI use (0); birthweight (5.5); prematurity (4.2); BMI (3.2); SBP (7.3).

In a longitudinal cohort of children with CKD, we found that higher
levels of DAP metabolites were associated with increased urinary
excretion of KIM-1 over time, suggesting subclinical kidney injury.
However, although DAP metabolites were associated with lower eGFR at
baseline, there was a trend of higher eGFR over follow-up and no as
sociation with UPCR, SBP, DBP, or time to RRT. On the biomarker level,
4
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Table 2
Distributions of urinary metabolites of OP pesticides over time, Chronic Kidney Disease in Children Study (CKiD), 2005–2015 and comparison with National Health
and Nutrition Examination Survey (NHANES) samples, 2011–2012.
NHANES 2011-2012a

Percentile
Biomarker

LOD

Individual OP pesticide metabolites
DMP (ng/ml)
0.0532
DEP (ng/ml)
0.0544
DMTP (ng/ml)
0.00492
DETP (ng/ml)
0.01796
DMDTP (ng/ml)
0.0024
DEDTP (ng/ml)
0.0334
OP pesticide groups
∑
DM (nmol/L)d
–
∑
–
DE (nmol/L)e
∑
f
DAP (nmol/L)
–

b

%<LOD

GM

25th

50th

75th

95th

ICC

%<LODb

GMc

22.4
1.7
0.08
3.6
2.6
90.1

1.03
1.11
1.36
0.17
0.12
–

0.54
0.55
0.49
0.08
0.05
<LOD

1.78
1.06
1.19
0.16
0.11
<LOD

3.91
2.15
3.44
0.37
0.30
<LOD

14.33
6.95
17.99
1.40
1.95
<LOD

0.18
0.24
0.26
0.28
0.22

1.9
1.1
5.1
27.1
43.8
95.9

2.54
2.49
1.53
0.30
0.21
–

–
–
–

23.8
8.76
37.8

9.64
4.40
16.44

24.80
8.38
36.85

60.71
16.56
79.72

261.87
53.50
299.23

0.26
0.26
0.26

–
–
–

36.2
19.3
64.8

Abbreviations: DAP, dialkyl phosphate; DE, diethyl; DM, dimethyl; DMP, dimethylphosphate; DEP, diethylphosphate; DMTP, dimethylthiophosphate; DETP, dieth
ylthiophosphate, DMDTP, dimethylphosphorodithidate; DEDTP, diethyldithiophosphate; LOD, limit of detection; ICC, intraclass correlation coefficient; NHANES,
National Health and Nutrition Examination Survey.
a
Among participants aged 6–19 years.
b
Limit of detection for all DAP metabolites measured by NHANES was 0.1 ng/ml.
c
Geometric means were not calculated for chemicals with ≥ 50% of measures < LOD.
d ∑
DM is the molar sum of DMP, DMTP, and DMDTP.
e ∑
DE is the molar sum of DEP and DETP.
∑
f
DAP is the molar sum of DMP, DEP, DMTP, DETP, and DMDTP.

oxidative stress as the central mechanism by which OPs induce acute
kidney injury (Poovala et al., 1999; Poovala et al., 1998). In addition,
toxicologic studies among diazinon and chlorpyrifos-treated rats and
mice have shown dose-dependent increases in reactive oxygen species
and oxidative stress in tissues and declines in renal antioxidant enzyme
activity (Jafari et al., 2012; Ma et al., 2013; Shah and Iqbal, 2010). Our
findings of diethyl metabolites associated with increased 8-OHdG are
particularly consistent with this given that diazinon and chlorpyrifos are
two species that metabolize to diethyl metabolites (Centers for Disease
Control and Prevention, 2009). Finally, although we did not observe
associations with lipid peroxidation (i.e., F2-isoprostane), this was likely
due to the smaller sample size.
In addition, the documentation of elevated urinary KIM-1 but not
NGAL in relation to OP exposure is consistent with what is known about
the localization of these biomarkers along the nephron. While NGAL is
primarily expressed in the distal tubule, KIM-1 is detected in the prox
imal convolute tubule (Bank et al., 2017; Bieniaś et al., 2015). Because
of greater bulk uptake of environmental chemicals by the proximal
segments, this may account for the stronger association between OP
exposure and urinary excretion of KIM-1 in the CKID cohort.
Our study benefited from prospective collection of biospecimens
over time and throughout the course of CKD among a well characterized
cohort of children. We measured urinary biomarkers of OP pesticides
multiple times within each individual, which allowed us to examine the
potential impact of cumulative exposure over time. By leveraging the
biobank of serially collected samples, this statistical approach com
pensates for the substantial intra-individual variability in these mea
sures due to their non-persistence and short biologic half-lives (Casas
et al., 2018). This was a significant improvement on previous studies
that have primarily utilized single spot urine samples. This longitudinal
study design and serial collection of biologic specimen also allowed for
the repeated measurement of tubular injury and oxidative stress bio
markers over time. In conjunction with the clinical renal and cardio
vascular measures collected within the CKiD study protocol, this
provided for a comprehensive picture of the trajectory of renal function
over time.
Limitations of this study included the use of urine as the matrix for
measuring biomarkers of exposure (i.e. OP pesticides) and effect (i.e.,
tubular injury and oxidant stress). Kidney dysfunction is known to affect
urinary solute excretion, and those with severe CKD have been shown to
have reduced excretory capacity owing to impaired glomerular filtration

Table 3
∑
Distributions of urinary DAP (nmol/L) by CKiD study visit, 2005–2015.
Percentiles
Baseline
Year 1
Year 2
Year 3
Year 4
Year 5

Geometric mean

25th

50th

75th

48.0
39.7
41.9
31.4
30.5
27.8

20.2
16.7
19.2
14.7
13.3
13.5

43.4
38.8
38.5
32.1
33.8
25.8

109.1
87.2
80.2
67.7
61.3
51.3

Abbreviations: DAP, dialkyl phosphate.

DAPs were not associated with NGAL, but ΣDE and especially DEP was
associated with increased KIM-1 concentrations. Lastly, all DAP me
tabolites, again especially DE metabolites, were associated with greater
urinary concentrations of 8-OHdG over time, indicative of increased
oxidant stress.
Despite an inconsistent association that varied over time with eGFR,
our findings suggest no other associations with clinical renal outcomes,
but evidence of subclinical renal damage as assessed by tubular injury
and oxidant stress biomarkers. Although there was no association with
time to RRT, proteinuria, or blood pressure, we did observe an inverted
J-shaped association with eGFR that persisted across several parame
terizations of exposure, stratifications by baseline eGFR and glomerular
disease type, and control for area-level socioeconomic status. Based on
studies showing associations between pesticide exposures and ESKD
(Lebov et al., 2016; Lebov et al., 2015), we hypothesized that such an
association with eGFR could be due to OP exposure-induced ESKD and
thus discontinued follow-up in those who reached this endpoint in the
CKiD study. In other words, if those vulnerable to OP exposure dropped
out of the study over time due to ESKD/RRT (i.e., CKiD exclusion
criteria), it may appear that DAPs were positively associated with renal
function among the remaining participants in the study in the later years
of follow-up. However, the lack of an association between DAPs and
time to ESKD/RRT does not support this possibility. At present, we do
not have a satisfactory explanation for the inverted J-shaped trajectory
of eGFR changes over time and OP exposure.
Our findings of increased 8-OHdG, indicating oxidant-mediated DNA
damage, are consistent with the hypothesis that OPs affect renal func
tion through induction of oxidant stress. In vitro studies have identified
5
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Fig. 1. Associations between ln-transformed DAP metabolite groups and eGFR by study visit shown as β-coefficients on the y-axis. Estimates were derived from
adjusted linear mixed-effects models and correspond to a 1- standard deviation change in each ln-transformed DAP exposure.
Table 4
Associations between ln-transformed chemical exposures and eGFR, ln-transformed urinary protein-to-creatinine ratio, SBP z-score, and DBP z-score from linear
mixed-effects models.
eGFR (ml/min/1.73 m2)a (N = 2024)
β
DMP*
DEP*
DMTP*
DETP*
DMDTP*
∑
DM*
∑
DE*
∑
DAP*

DMP
DEP
DMTP*
DETP
DMDTP
∑
DM*
∑
DE
∑
DAP

95% CI

p

− 0.629
− 1.296,
− 1.306
− 1.983,
− 0.87
− 1.515,
− 0.973
− 1.611,
− 0.652
− 1.313,
− 0.812
− 1.465,
− 1.317
− 1.982,
− 1.014
− 1.665,
SBP Z-scoreb (N = 2035)
β
95% CI

0.038
− 0.629
− 0.225
− 0.335
0.009
− 0.159
− 0.652
− 0.363

− 0.009
− 0.008
0.007
− 0.008
− 0.007
− 0.014
− 0.008
− 0.003

0.032
0.033
0.076
0.035
0.034
0.040
0.035
0.040

−
−
−
−
−
−
−
−

0.050,
0.049,
0.062,
0.051,
0.048,
0.046,
0.051,
0.046,

Ln-UPCRa (N = 1969)
В

0.064
<0.0001
0.008
0.003
0.053
0.015
<0.0001
0.002

DMP
DEP
DMTP
DETP
DMDTP*
∑
DM
∑
DE
∑
DAP

p
0.671
0.694
0.839
0.721
0.739
0.68
0.723
0.9

DMP
DEP
DMTP
DETP
DMDTP
∑
DM
∑
DE
∑
DAP

95% CI

p

− 0.001
− 0.036,
− 0.029
− 0.066,
− 0.006
− 0.041,
− 0.047
− 0.084,
0.014
− 0.047,
− 0.005
− 0.042,
− 0.038
− 0.075,
− 0.017
− 0.054,
DBP Z-scoreb (N = 2034)
В
95% CI

0.034
0.008
0.029
− 0.010
0.075
0.032
− 0.001
0.020

0.016
0.001
0.028
0.006
0.003
0.026
0.004
0.023

0.055
0.040
0.069
0.047
0.042
0.067
0.045
0.064

−
−
−
−
−
−
−
−

0.023,
0.038,
0.013,
0.035,
0.036,
0.015,
0.037,
0.018,

0.956
0.133
0.744
0.012
0.66
0.792
0.052
0.36
p
0.432
0.954
0.169
0.76
0.878
0.211
0.831
0.267

Abbreviations: eGFR: estimated glomerular filtration rate; UPCR: urinary protein to creatinine ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; DAP,
dialkyl phosphate; DE, diethyl; DM, dimethyl; DMP, dimethylphosphate; DEP, diethylphosphate; DMTP, dimethylthiophosphate; DETP, diethylthiophosphate,
DMDTP, dimethylphosphorodithidate; DEDTP, diethyldithiophosphate.
β: estimate per SD change.
*
Exposure has significant interaction with time (p < 0.05) and estimate for exposure at baseline is presented here; time-specific estimates were plotted in Fig. 1 and
Supplemental Tables 2–4.
a
The model controlled for time since baseline, age, gender, race/ethnicity, glomerular status, birthweight, low birthweight prematurity, ARB, ACEI, BMI-Z score,
SBP Z-score (all measured at each patient’s first visit) and creatinine.
b
The model controlled for time since baseline, age, gender, race/ethnicity, glomerular status, birthweight, low birthweight, prematurity, ARB, ACEI, BMI-Z score
(all measured at each patient’s first visit) and creatinine.

and/or diminished tubular secretion (Weaver et al., 2016). Therefore,
urinary biomarker concentrations may be affected, especially in those
with the most advanced CKD. Consistent with this theory is our obser
vations of decreasing urinary DAP concentrations over the course of

follow-up among CKiD children and lower urinary levels of DAPs among
CKiD children compared with healthy children from NHANES. However,
we note that these differences may also be due to variation in residential
proximity to agriculture, diet, home and garden OP pesticide use, and
6

M.H. Jacobson et al.

Environment International 155 (2021) 106597

Table 5
Adjusted Hazard Ratios (HR) and 95% Confidence Intervals (CI) from Cox
Proportional Hazards Models for the associations of ln-transformed chemical
exposures with time to renal replacement therapy and/or end-stage renal
disease among 538 CKiD participants (n = 179 events) with baseline exposure
data.
DMP
DEP
DMTP
DETP
DMDTP
∑
DM
∑
DE
∑
DAP

Table 7
Associations between ln-transformed chemical exposures and ln-transformed
oxidative stress biomarkers from linear mixed-effects models.
ln-8-OHdG (N = 2029)
95% CI

P

β

95% CI

p

0.039

0.006,
0.072
0.080,
0.150
0.031,
0.101
0.094,
0.204
0.048,
0.114
0.030,
0.100
0.089,
0.159
0.053,
0.123

0.024

− 0.045

0.403

<0.0001

− 0.063

<0.0001

0.094

<0.0001

0.052

<0.0001

0.099

<0.0001

0.02

<0.0001

− 0.045

<0.0001

0.008

− 0.151,
0.061
− 0.171,
0.045
− 0.018,
0.206
− 0.050,
0.154
− 0.015,
0.213
− 0.090,
0.130
− 0.151,
0.061
− 0.104,
0.120

HR

95% CI

DMP

0.99
1.15
0.95
0.89
0.83
0.95
1.02
0.99

0.85,
0.84,
0.76,
0.70,
0.68,
0.76,
0.74,
0.75,

DEP

0.115

DMTP

0.066

DETP*

0.149

DMDTP

0.081

∑
DM

0.065

∑
DE

0.124

∑
DAP

0.088

1.16
1.58
1.20
1.13
1.02
1.20
1.41
1.30

Abbreviations: DAP, dialkyl phosphate; DE, diethyl; DM, dimethyl; DMP,
dimethylphosphate; DEP, diethylphosphate; DMTP, dimethylthiophosphate;
DETP, diethylthiophosphate, DMDTP, dimethylphosphorodithidate; DEDTP,
diethyldithiophosphate.
All models controlled for age, gender, race/ethnicity, glomerular status,
birthweight, low birthweight, prematurity, ARB, ACEI, BMI-Z score, SBP Zscore (all measured at each patient’s first visit) and creatinine.

ln-KIM-1 (N = 1925)

β

95% CI

P

β

95% CI

p

DMP

− 0.018

0.649

0.049

− 0.073

0.077

0.123

DMTP

− 0.012

0.77

0.03

DETP

− 0.029

0.486

0.046

DMDTP

− 0.07

0.077

− 0.008

∑
DM

− 0.002

0.961

0.051

∑
DE

− 0.065

0.124

0.112

∑
DAP

− 0.024

0.56

0.059

− 0.012,
0.110
0.060,
0.186
− 0.033,
0.093
− 0.017,
0.109
− 0.069,
0.053
− 0.012,
0.114
0.047,
0.177
− 0.006,
0.124

0.114

DEP

− 0.096,
0.060
− 0.155,
0.009
− 0.092,
0.068
− 0.109,
0.051
− 0.147,
0.007
− 0.082,
0.078
− 0.147,
0.017
− 0.106,
0.058

0.252
0.1
0.315
0.092
0.721
0.41
0.887

Abbreviations: 8-OHdG: 8-hydroxy-2′ -deoxyguanosine; DAP, dialkyl phosphate;
DE, diethyl; DM, dimethyl; DMP, dimethylphosphate; DEP, diethylphosphate;
DMTP, dimethylthiophosphate; DETP, diethylthiophosphate, DMDTP, dime
thylphosphorodithidate; DEDTP, diethyldithiophosphate.
All models controlled for time since baseline, age, gender, race/ethnicity,
glomerular status, birthweight, low birthweight, prematurity, ARB, ACEI, BMI-Z
score, SBP Z-score (all measured at each patient’s first visit) and creatinine.
β: estimate per SD change.
*
Exposure has significant interaction with time (p < 0.05) and estimate for
exposure at baseline is presented here; time-specific estimates are shown in
Supplemental Table 5.

Table 6
Associations between ln-transformed chemical exposures and ln-transformed
tubular injury biomarkers from linear mixed-effects models.
ln-NGAL (N = 1925)

ln-F2-Isoprostane (N = 1045)

β

<0.0001

confidence intervals, it is a more accurate reflection of the true exposure
environment over time. Another limitation was that we had missing data
on covariates and outcomes that led to different sample sizes for each
regression, most notably F2-isoprostane. Finally, we did not have data on
dietary information, which could act as a confounder between OP
pesticide exposure and renal function. Because OP pesticide exposure is
related to consumption of conventional produce (Curl Cynthia et al.,
2003), those with greater fruit and vegetable consumption have greater
OP pesticide exposure levels (Berman et al., 2020; Cequier et al., 2017).
Overall, those who eat diets rich in fruits and vegetables may have
healthier lifestyles and better renal function (Banerjee et al., 2019),
which could confound associations with OP exposure. Therefore,
without controlling for dietary factors, this could bias results in the di
rection of improved renal function. Another possible way this could
affect results is through potential dietary restrictions. For example, po
tassium restriction to prevent hyperkalemia and the associated reduced
protein intake could potentially explain the positive effect of OP expo
sure and maintenance of eGFR. However, the majority of patients in the
CKiD cohort had non-glomerular disease (i.e., CAKUT). These children,
in contrast to those with glomerular disorders, generally have sustained
urine output and normal serum potassium levels and do not require
potassium restriction. Moreover, there was no difference in effect of OP
exposure in the non-glomerular versus glomerular subgroups, arguing
against an effect of potassium restriction. Finally, we also note that there
were other correlates of exposure that were not measured in this study
that may have acted as confounding variables, such as climate, urban
icity, drinking water supply, and other environmental conditions.
From a public health perspective, these findings are significant
because in contrast to many CKD risks which are not amenable to
modification, OP body burdens can be ameliorated through consump
tion of organic foods. Studies have shown that interventions that
introduce organic in the place of conventional produce effectively and
rapidly reduce pesticide and herbicide exposure, evidenced by lower
and even non-detectable levels of urinary pesticides (Bradman et al.,
2015; Lu et al., 2006). Additional studies specifically among children

0.349
0.152
0.805
0.11
0.001
0.069

Abbreviations: NGAL: Neutrophil gelatinase-associated lipocalin; KIM-1: Kidney
Injury Molecule-1; DAP, dialkyl phosphate; DE, diethyl; DM, dimethyl; DMP,
dimethylphosphate; DEP, diethylphosphate; DMTP, dimethylthiophosphate;
DETP, diethylthiophosphate, DMDTP, dimethylphosphorodithidate; DEDTP,
diethyldithiophosphate.
All models controlled for time since baseline, age, gender, race/ethnicity,
glomerular status, birthweight, low birthweight, prematurity, ARB, ACEI, BMI-Z
score, SBP Z-score (all measured at each patient’s first visit) and creatinine.
β: estimate per SD change.

the use of OP pesticides in school settings. We observed similar trends in
our earlier study of bisphenol A and phthalate exposure in this cohort
(Malits et al., 2018). Further study is needed to explain these differences
in chemical exposure levels. Despite these differences in exposure, in
sensitivity analyses, we observed that associations between DAPs and
renal outcomes did not vary by baseline renal function. This suggests
that our observed associations were not artifacts of any potentially
impaired excretion among those with the most reduced renal function.
In addition, urinary DAPs reflect recent exposure and showed low reli
ability over time owing to their non-persistence, which posed a unique
challenge in statistical analyses. However, unlike previous studies that
have used a single spot urine sample to quantify exposure (Kataria et al.,
2015; Trasande et al., 2020), our study incorporated this variability into
all estimates. Although this likely decreased precision and led to larger
7
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with CKD are needed to confirm these observations in this vulnerable
subgroup given potential differences in excretion.
This study has potential implications for CKDu research. Despite the
lack of consistent associations with clinical endpoints, we documented
renal injury on the subclinical level that indicates tubular damage and
thus the potential for clinically apparent changes with extended followup. Specifically, elevated KIM-1 and 8-OHdG have been linked with
faster CKD decline to ESKD, incident albuminuria, cardiovascular dis
ease, and premature mortality (Alderson et al., 2016; Bhavsar et al.,
2012; Park et al., 2017; Peralta et al., 2012; Schei et al., 2018; Walther
et al., 2019). This supports the hypothesis that subclinical injury over
time may eventually manifest as CKDu in the absence of traditional risk
factors for CKD like hypertension or obesity. While we note that this
study was not comprised of patients with CKDu, and that CKD diagnosed
in children differs from CKDu in that the causes are well understood
(including congenital anomalies of the kidney and urinary tract
(CAKUT), hereditary nephropathies, and chronic glomerulonephritis
(Becherucci et al., 2016; Harambat et al., 2012)); in documenting an
association between OP pesticide exposure and subclinical evidence of
kidney injury, it still may be of practical relevance to that line of
research (Valcke et al., 2017). Furthermore, this is the first study on
pesticides and CKD conducted among children, which lays the ground
work for further studies of whether the origins of CKDu may emerge in
early life.
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